nitrendipine has been researched along with Liver Cirrhosis in 1 studies
Nitrendipine: A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive.
nitrendipine : A dihydropyridine that is 1,4-dihydropyridine substituted by methyl groups at positions 2 and 6, a 3-nitrophenyl group at position 4, a ethoxycarbonyl group at position 3 and a methoxycarbonyl group at position 5. It is a calcium-channel blocker used in the treatment of hypertension.
Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dylewicz, P | 1 |
| Kirch, W | 1 |
| Santos, SR | 1 |
| Hutt, HJ | 1 |
| Mönig, H | 1 |
| Ohnhaus, EE | 1 |
1 other study available for nitrendipine and Liver Cirrhosis
| Article | Year |
|---|---|
Bioavailability and elimination of nitrendipine in liver disease.
Topics: Administration, Oral; Adult; Biological Availability; Blood Pressure; Female; Half-Life; Heart Rate; | 1987 |